Medicines Optimisation Centricity
Aspire Pharma initiated and funded a series of workshops run and facilitated by HSJ (previously Wilmington Healthcare). The workshops brought together key NHS and Pharmacy stakeholders to debate and discuss four themes:
MOC 2026
Held in March 2026
In March 2026, HSJ Advisory surveyed 39 NHS pharmacy stakeholders across acute, primary care and system-level roles. The findings offer a useful, evidence-based picture of where deprescribing activity currently stands, and what would help it progress.
Learn more about the findings of workshop series 4 and read the ‘Medicines Optimisation Centricity: Understanding the deprescribing landscape’ white paper:
Workshop Series Three
Held in June 2025
This roundtable event, brought together key pharmacy stakeholders to debate and discuss the value of medicines in the patient pathway. Of particular focus was understanding patient centric access to medicines and how to ensure that services are delivered with patients in mind.
Learn more about the findings of workshop series 3 and read the ‘Medicines Optimisation Centricity: What is the value of medicines in the patient pathway?’ white paper:
Workshop Series Two
Held in July 2024
This workshop explored whether medicines optimisation could be creating health inequalities/inequities. The roundtable offered a chance to reflect on medicines optimisation within the new integrated care landscape. It examined whether it truly achieves its intended goals, or if the current approach actually exacerbates inequalities and negatively impact specific groups within our population.
Learn more about the findings of workshop series 2 and read the ‘Medicines Optimisation Centricity: Is it creating health inequalities?’ white paper:
Workshop Series One
Held in March 2023
This series explored the practicalities of medicine optimisation, sharing best practices to determine “the way forward” to ensuring optimal medicine optimisation.
Learn more about the findings of workshop series 1 and read the ‘Medicines Optimisation Centricity: The way forward’ white paper:
MAT-UK-MOC-0018-2 | October 2026
© Copyright HSJ in partnership with Aspire Pharma Limited
